MITABAN DIN 00813842
Health Canada record
| Active ingredient(s) | AMITRAZ 19.9 % |
|---|---|
| Dosage form | Solution |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1989 |
| Current status date | 01-Aug-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15379 | 2014-03-11 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 8990 | 2007-08-24 | Supplement to a New Drug Submission (SNDS) | ALTERNATE MANUFACTURING SITE |
| 5321 | 2004-08-31 | New Drug Submission (NDS) | |
| 6138 | 2002-01-22 | New Drug Submission (NDS) | |
| 6787 | 1997-06-26 | New Drug Submission (NDS) |
International API supply for AMITRAZ
1 active FDA Drug Master Files.
Request a quote for MITABAN